About Namsa

NAMSA serves over 3,000 medical device and IVD manufacturers worldwide, conducting testing, preclinical research, clinical trials, and regulatory consulting for more than 100,000 devices annually. Founded in 1967, the company operates GLP-compliant facilities across North America, Europe, and Asia. NAMSA's expertise spans all device risk classes, with results trusted by the US FDA, EU Notified Bodies, and global authorities. Manufacturers gain a holistic regulatory roadmap by consolidating testing, clinical trials, and compliance services under one partner. This integrated approach shortens time to market, increases approval success, and reduces costs through direct oversight and seamless coordination across all development phases.